BackBlue Vision A/S Overview

Blue Vision A/S EBIT

Latest ebit for BLVIS-A.CO: $-18M, below the Healthcare sector average of $1.9T.

Get informed when a big investor buys or sells

+ Follow

Quarterly EBIT

-$640.50K
↑ 92.32% YoY

As of Jun 30, 2026

Annual EBIT (TTM)

-$18.00M
↑ 30.79% YoY

Trailing 12 months ending Jun 30, 2026

Average EBIT (Comparison Companies)

EBIT History

EBIT Comparison

Annual EBIT Growth Rate (%)

Annual EBIT Growth (Absolute)

Blue Vision A/S (BLVIS-A.CO) FAQ

The latest EBIT for BLVIS-A.CO is $-18M as of June 2026. That compares with $-26M in the prior-year period — up 30.8% year over year. That is below the Healthcare sector average of $1.9T. Investors often review this figure alongside Blue Vision A/S's historical trend and sector peers before judging valuation or financial health.

Over the past year, BLVIS-A.CO's EBIT moved from $-26M to $-18M — a 30.8% year-over-year increase. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Blue Vision A/S's operating scale or balance-sheet position.

Against Healthcare companies, BLVIS-A.CO currently prints $-18M for EBIT, while the sector average sits near $1.9T. That is roughly 100.0% below the sector mean. Large gaps often invite a closer look at Blue Vision A/S's growth, margins, and balance sheet.

A EBIT figure of $-18M for BLVIS-A.CO is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The Healthcare average is about $1.9T. Explore the charts below for those layers of context.

After noting BLVIS-A.CO's EBIT ($-18M), review year-over-year change from $-26M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.